citizen reporter
. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.: "targeted cgrp small molecule antagonists for acute migraine therapy."
.
.
'indian ip and liabilities law barrier to pharma r&d investment'
.
as tick season arrives into full swing in canada, officers in manitoba are warning the citizens that lyme disease is not the only thing to be on the lookout for.
.
.'indian ip and liabilities law barrier to pharma r&d investment'
.